ELIAS Animal Health is launching a blog series that shares our story. More than that, it will hopefully serve as a guide for entrepreneurs who want to turn a great idea into a thriving company. Our founder, Tammie Wahaus, shares her thoughts, insights and advice in this series. Our Goals While working as the CFO of a human health company, I was pursuing an idea that led to the founding of ELIAS: apply the immunotherapy technology we were developing for humans as a cutting-edge cancer treatment for dogs. My goals were to advance human health by bringing safe, effective products to the veterinary market that improved the quality of life for veterinary cancer patients at a price that was competitive in the animal health marketplace. Three Proof Points While ideas are often the catalyst for launching a company, they don’t grow a company. In life sciences, you must prove three [...]

One in four dogs will be diagnosed with cancer in their lifetimes, and that’s only one of many diseases that can present a pet owner with a difficult health decision for their pet. This article highlights that an increasing number of pet owners are choosing to mitigate the financial challenges inherent in advanced treatments by purchasing pet insurance. According to Sarah A. Moser in a recent DVM360 article, the percentage of pets covered by insurance continues to grow, and looks to be accelerating with the millennial generation owning an ever increasing percent of total dogs and cats. Our inquiries indicate that ECI® from ELIAS is covered by many insurance companies today, when prescribed by a veterinarian. veterinarybusiness.dvm360.com/future-trend-millennials-could-be-boost-pet-insurance-needs